Nobel laureate Shimon Sakaguchi reflects on the role of regulatory T cells in peripheral immune tolerance and how the cells ...
In a breakthrough that could potentially rewrite the prevention and treatment of cancer, scientists have discovered how ...
In a breakthrough cancer therapy development, scientists at MIT and Harvard Medical School created a new way of designing ...
A Weill Cornell Medicine team has found that triple-negative breast cancer depends on the enzyme EZH2 to spread. By silencing ...
Triple negative breast cancer (TNBC) is one of the most aggressive and hardest forms of breast cancer to treat, but a new ...
Researchers have discovered that an enzyme called EZH2 drives TNBC cells to divide abnormally, which enables them to relocate ...
Former President Joe Biden is now receiving radiation therapy for his prostate cancer, a spokesperson for the former ...
University of Wisconsin-Madison Professor Zachary Morris discusses his research into the field of theranostics and the “team ...
Cancer researcher Chi Van Dang studies pharmacokinetics—the way the body absorbs, distributes, metabolizes, and excretes a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback